Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dextrose monohydrate + sodium lactate + calcium chloride + potassium chloride + sodium chloride is a sterile intravenous crystalloid and carbohydrate solution corresponding to **Lactated Ringer's and 5% Dextrose Injection**. It is used as a parenteral source of water, electrolytes, and calories, and as an alkalinizing agent. Pharmacologically, it does not act through a single receptor target; instead, it expands and replenishes the extracellular fluid compartment, supplies dextrose as a readily metabolized carbohydrate source, replaces key electrolytes including sodium, potassium, calcium, and chloride, and provides lactate that is metabolized to bicarbonate to help buffer metabolic acidosis. The product is used for replacement of extracellular fluid and electrolyte losses and for maintenance therapy in adults and pediatric patients who require intravenous fluid, electrolyte, and limited caloric support. Publicly described manufacturers include Hospira and ICU Medical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dextrose monohydrate + sodium lactate + calcium chloride + potassium chloride + sodium chloride.